These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190 [TBL] [Abstract][Full Text] [Related]
8. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033 [TBL] [Abstract][Full Text] [Related]
12. Local oestrogen for vaginal atrophy in postmenopausal women. Lethaby A; Ayeleke RO; Roberts H Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677 [TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Scheffers CS; Armstrong S; Cantineau AE; Farquhar C; Jordan V Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011066. PubMed ID: 25879093 [TBL] [Abstract][Full Text] [Related]
14. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Lara LA; Cartagena-Ramos D; Figueiredo JB; Rosa-E-Silva ACJ; Ferriani RA; Martins WP; Fuentealba-Torres M Cochrane Database Syst Rev; 2023 Aug; 8(8):CD009672. PubMed ID: 37619252 [TBL] [Abstract][Full Text] [Related]
15. Bioidentical hormones for women with vasomotor symptoms. Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272 [TBL] [Abstract][Full Text] [Related]